At the IGTP TODAY
The project incubator of the Innomed program will help participating teams advance the valorisation and development of their projects through training capsules, concluding with a Demo Day.
Researchers from IGTP participated today in the fourth edition of Ciència al carrer: Fira d'ESO amb mirada STEAM, an educational initiative to engage students with science through dynamic and interactive activities.
For the fourth consecutive year, researchers from IGTP are taking part in the #científiques initiative, bringing science closer to schools and creating female role models in the framework of the International Day of Women and Girls in Science (11 February).
The symposium has become a key event for sharing knowledge and experiences around these conditions.
A year of continuity in the committee's activity, marked by the monitoring of the Institute's strategic lines and active involvement in key governance initiatives.
The CMCiB co-organised a Cafè GIPS this Wednesday focusing on the challenges and opportunities posed by alternative models to animal experimentation in biomedical research. The session brought together professionals from research, bioengineering, innovation and industry with the aim of sharing experiences and perspectives on new approaches aligned with the 3Rs framework.
The CMCiB of the Germans Trias i Pujol Research Institute (IGTP) has renewed for the third consecutive time its certificate of compliance with Good Laboratory Practices (GLP) in accordance with Directive 2004/9/EC.
The Escoles Sentinella project, coordinated by the CEEISCAT Group at IGTP, presented the main results of its fifth and final academic year. This initiative has shown that the network is viable and generates relevant scientific evidence on school health through collaboration between schools, researchers and public institutions.
IGTP has launched the European project TB-SPECTRUM, funded under the Horizon Europe programme through the MSCA Staff Exchanges scheme and coordinated by IGTP. A kick-off meeting held online brought together researchers, clinicians, and representatives from academic and non-academic institutions across Europe, Africa, and the United States, alongside members of the project's External Scientific and Ethics Advisory Boards.
Nearly one hundred professionals from the Innomed Program took part in this visit, an opportunity to gain first-hand insight into AstraZeneca’s scientific activity and explore new opportunities for collaboration.
